26ᵗʰ European Hematology Association (EHA) Annual Congress - X4 Pharmaceuticals

26ᵗʰ European Hematology Association (EHA) Annual Congress

26ᵗʰ European Hematology Association (EHA) Annual Congress

June 2021

Preliminary Clinical Data From a Phase 1b Study of Mavorixafor and Ibrutinib in Patients With Waldenström’s Macroglobulinemia With MYD88 and CXCR4 Mutations

© 2023 X4 Pharmaceuticals, Inc. All rights reserved. Terms of Use | Privacy Policy